The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study

BACKGROUND: Tenofovir disoproxil fumarate (TDF), emtricitabine (FTC), and efavirenz (EFV) are the three components of the once-daily, single tablet regimen (Atripla) for treatment of HIV-1 infection. Previous cell culture studies have demonstrated that the double combination of tenofovir (TFV), the...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Joy Y, Ly, John K, Myrick, Florence, Goodman, Derrick, White, Kirsten L, Svarovskaia, Evguenia S, Borroto-Esoda, Katyna, Miller, Michael D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693498/
https://www.ncbi.nlm.nih.gov/pubmed/19439089
http://dx.doi.org/10.1186/1742-4690-6-44

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693498/
https://www.ncbi.nlm.nih.gov/pubmed/19439089
http://dx.doi.org/10.1186/1742-4690-6-44

Ejemplares similares